Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase | 91 |
| BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase | 55 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase | 1 | 4 | 4 | 2 | 1 | 6 | 5 |
File Downloads
| Views | |
|---|---|
| hdl_106019.pdf(legacy) | 150 |
| hdl_106019.pdf | 61 |
Top Country Views
| Views | |
|---|---|
| United States | 59 |
| Australia | 26 |
| China | 15 |
| France | 10 |
| Netherlands | 8 |
| Vietnam | 8 |
| Argentina | 2 |
| Germany | 2 |
| Hong Kong SAR China | 2 |
| Oman | 2 |
Top City Views
| Views | |
|---|---|
| Kaleen | 19 |
| Ashburn | 18 |
| Fairfield | 11 |
| Hanoi | 8 |
| Rotterdam | 8 |
| Zhengzhou | 5 |
| Beijing | 4 |
| Cambridge | 2 |
| Central | 2 |
| Melbourne | 2 |